Lunit Reviews

Athena Security delivers an industry-leading, AI-powered concealed weapons detection system and entryway security platform for hospitals, K–12 schools, casinos, places of worship, government buildings, and other high-traffic environments where speed, accuracy, and safety are critical. The Apollo 500 concealed weapons detection system enables seamless walk-through screening, using advanced AI to accurately distinguish real threats such as firearms and knives from everyday items like phones and keys—maximizing throughput while reducing false alarms. Athena’s AI-powered baggage X-ray scanner modernizes screening with Apple iPad-based control, replacing legacy consoles with an intuitive interface that improves usability, reduces training time, enables remote operation, and enhances threat detection through automated identification of suspicious items. Athena’s Hospital Visitor Management System delivers deeper intelligence than traditional systems, including visitor history, prior incidents, and person-of-interest alerts—empowering faster, more informed decisions. Integration with EPIC strengthens healthcare workflows while maintaining high security standards. First-of-its-kind innovations include the Ambulance Bay Weapons Detection System (AB-WDS) purpose built for hopsitals for screening stretcher patients and a secondary screening solution for feet and bags, reducing human error in courthouses and government facilities. Built for compliance and real-world deployment across U.S. regions, Athena aligns with DHS best practices and evolving state regulations, including healthcare security mandates AB2975. Telepresence and AR alert glasses provide real-time operational support, while all systems unify into one platform for centralized monitoring, analytics, and enterprise reporting.

It's clear that enhancing your testing efforts could help identify bugs sooner, yet effective QA testing often demands significant time, effort, and resources. With MuukTest, engineering teams can achieve up to 95% coverage of end-to-end tests in a mere three months. Our team of QA specialists is dedicated to creating, overseeing, maintaining, and updating E2E tests on the MuukTest Platform for your web, API, and mobile applications with unparalleled speed. After reaching 100% regression coverage within just eight weeks, we initiate exploratory and negative testing to discover bugs and further elevate your testing coverage. By managing your testing frameworks, scripts, libraries, and maintenance, we significantly reduce the time you spend on development. Additionally, we take a proactive approach to identify flaky tests and false results, ensuring that your testing process remains accurate. Consistently conducting early and frequent tests enables you to catch errors during the initial phases of the development lifecycle, thus minimizing the burden of technical debt in the future. By streamlining your testing processes, you can improve overall product quality and enhance team productivity.

Ibex Medical Analytics leads the way in the application of AI technology for cancer diagnostics within pathology. Our multidisciplinary team consists of entrepreneurs, software engineers, data scientists, and healthcare professionals who share a common goal: to transform cancer diagnostics through artificial intelligence, ultimately improving the quality of patient care. As the number of tests conducted each year increases, pathologists encounter considerable challenges in providing accurate and timely evaluations. To tackle these issues, Ibex utilizes AI to develop clinical-grade solutions designed to detect cancer with a level of precision comparable to that of human pathologists. The Galen Platform uses sophisticated algorithms to analyze imaging, identify and categorize cancer in biopsy samples, and emphasize other clinically relevant findings, which aids pathologists in reducing diagnostic mistakes and enhancing their workflow efficiency. In particular, Ibex's Galen™ Prostate and Galen™ Breast tools are groundbreaking AI-driven cancer detection solutions that have been integrated into standard clinical practice in pathology laboratories, demonstrating proven effectiveness in identifying cancer cases that were previously overlooked. As we persist in our quest for progress, our dedication to advancing cancer detection and improving patient outcomes continues to be resolute and inspiring for the entire medical community.